Search
Now showing items 1-1 of 1
The cost-effectiveness of hypertension pharmacotherapy in Serbia: A Markov model
(Taylor & Francis Ltd, Abingdon, 2012)
To date there is no Markov model to evaluate the cost-effectiveness of antihypertensive pharmacotherapies at national level in developing countries. The aim of our study was to evaluate different antihypertensives and ...